Brainomix, a company creating AI-powered imaging tools in stroke and lung fibrosis, has completed a £14m Series C investment round.  The University of Oxford spinout will use the funding to accelerate its US expansion, where it has recently secured 10 FDA clearances. Fresh funding will also support the firm in advancing its portfolio of AI-powered … Continue reading MedTech targeting strokes raises £14m to fuel US expansion